Ach T - Search Results

1

[Subjective sensations after intravitreal injection of bevacizumab].

Ach T, Dawczynski J, Königsdörffer E, Augsten R, Strobel J. Ach T, et al. Klin Monbl Augenheilkd. 2007 Mar;224(3):180-4. doi: 10.1055/s-2007-963035. Klin Monbl Augenheilkd. 2007. PMID: 17385118 Clinical Trial. German.

2

[Endothelial dysfunction of central retinal vessels: a prognostic parameter for diabetic retinopathy?].

Dawczynski J, Mandecka A, Blum M, Müller UA, Ach T, Strobel J. Dawczynski J, et al. Among authors: ach t. Klin Monbl Augenheilkd. 2007 Nov;224(11):827-31. doi: 10.1055/s-2007-963675. Klin Monbl Augenheilkd. 2007. PMID: 18034395 German.

3

Differential expression of tetraspanin CD9 in basal cell and squamous cell carcinomas of the skin and actinic keratosis.

Ach T, Ziemer M, Dawczynski J, Strobel J, Sauer G, Deissler H. Ach T, et al. Oncol Lett. 2010 Jan;1(1):37-40. doi: 10.3892/ol_00000006. Epub 2010 Jan 1. Oncol Lett. 2010. PMID: 22966252 Free PMC article.

4

Treatment of peripapillary choroidal neovascularization with intravitreal bevacizumab.

Hoeh AE, Schaal KB, Ach T, Dithmar S. Hoeh AE, et al. Among authors: ach t. Eur J Ophthalmol. 2009 Jan-Feb;19(1):163-5. doi: 10.1177/112067210901900128. Eur J Ophthalmol. 2009. PMID: 19123169

5

Long-term follow-up of OCT-guided bevacizumab treatment of macular edema due to retinal vein occlusion.

Hoeh AE, Ach T, Schaal KB, Scheuerle AF, Dithmar S. Hoeh AE, et al. Among authors: ach t. Graefes Arch Clin Exp Ophthalmol. 2009 Dec;247(12):1635-41. doi: 10.1007/s00417-009-1151-1. Epub 2009 Jul 26. Graefes Arch Clin Exp Ophthalmol. 2009. PMID: 19633982

6

Predictive factors for changes in macular edema in intravitreal bevacizumab therapy of retinal vein occlusion.

Ach T, Hoeh AE, Schaal KB, Scheuerle AF, Dithmar S. Ach T, et al. Graefes Arch Clin Exp Ophthalmol. 2010 Feb;248(2):155-9. doi: 10.1007/s00417-009-1167-6. Epub 2009 Sep 9. Graefes Arch Clin Exp Ophthalmol. 2010. PMID: 19763601

7

[Effect of intravitreal bevacizumab on pigment epithelial detachment in occult choroidal neovascularization].

Ruppenstein M, Ach T, Höh A, Dithmar S. Ruppenstein M, et al. Among authors: ach t. Ophthalmologe. 2010 Sep;107(9):827-30. doi: 10.1007/s00347-010-2166-z. Ophthalmologe. 2010. PMID: 20532523 German.

8

Intravitreal bevacizumab in vascular pigment epithelium detachment as a result of subfoveal occult choroidal neovascularization in age-related macular degeneration.

Ach T, Hoeh AE, Ruppenstein M, Kretz FT, Dithmar S. Ach T, et al. Retina. 2010 Oct;30(9):1420-5. doi: 10.1097/IAE.0b013e3181d87e97. Retina. 2010. PMID: 20543764

9

OCT patterns of macular edema and response to bevacizumab therapy in retinal vein occlusion.

Hoeh AE, Ruppenstein M, Ach T, Dithmar S. Hoeh AE, et al. Among authors: ach t. Graefes Arch Clin Exp Ophthalmol. 2010 Nov;248(11):1567-72. doi: 10.1007/s00417-010-1419-5. Epub 2010 Jul 2. Graefes Arch Clin Exp Ophthalmol. 2010. PMID: 20596719

10

[Autofluorescence of the Human Retinal Pigment Epithelium in Normal Aging and in Age-Related Macular Degeneration: Histology and Clinical Correlation].

Ach T, Bermond K. Ach T, et al. Klin Monbl Augenheilkd. 2019 May;236(5):672-681. doi: 10.1055/s-0043-109891. Epub 2017 Jul 6. Klin Monbl Augenheilkd. 2019. PMID: 28683482 German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

124 results

Search Page

Filters